| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.07 |